Eptinezumab is a humanised monoclonal antibody targeting CGRP (calcitonin gene-related peptide), which prevents CGRP binding to its receptor and may be used for migraine prevention.
Purity:
95.00%
CAS Number:
[1644539-04-7]
Target:
CGRP Receptor
* VAT and and shipping costs not included. Errors and price changes excepted